| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |